Prescribing DiGA: how to effectively prevent recourse claims
What SHI-accredited physicians and psychotherapists should know about the efficiency, documentation and billing of DiGA.
Prescribing in line with the indication is the most effective safeguard. Checking the indication, contraindications and patient group as stated in the DiGA directory and documenting the decision lays an essential foundation for complying with the efficiency requirement under § 12 SGB V.
DiGA do not affect your budget. Neither the pharmaceutical nor the remedies budget is affected. DiGA prescriptions fall outside the target volume (Richtgrößenvolumen), and no maximum number per quarter is currently set.
Audits are subject to conditions. Individual audits are carried out at the request of a statutory health insurer, and only where the regional audit agreement covers DiGA. This is not the case in every region of the Associations of SHI Physicians (KVs).

Preventing recourse claims (Regresse) in three steps
Compare the diagnosis, contraindications and patient group with the information in the DiGA directory.
Record the indication, the exclusion of contraindications and the medical necessity in the patient record.
One DiGA per Muster 16 prescription form or e-prescription. Bill accompanying services using the corresponding fee schedule item (GOP).
Who decides, and who may audit
You decide on every DiGA prescription individually, just as with medicines, remedies and medical aids. The benchmark is § 12 SGB V: services must be sufficient, appropriate and economical, and must not exceed what is necessary.
As a rule, statutory health insurers may not interfere with this decision. Once your prescription has been issued, they must provide the activation code.
Where there is reasonable suspicion, the regional joint audit bodies (Gemeinsame Prüfstellen) of the Associations of SHI Physicians and the statutory health insurers can audit individual prescriptions for efficiency. Whether DiGA are covered is set out in your regional audit agreement. It is worth checking this once for your KV region.
Where to find the prescription data
Everything you need for the prescription is listed in the DiGA directory under “Information for professionals”: pharmaceutical central number (PZN), duration of use, indication and patient group.
Your practice management system imports this information, sometimes with a technical delay. If a DiGA is not yet available there, open the directory online and copy the PZN and name onto the prescription by hand.
Your patients can also find information in the DiGA directory. Further guidance on prescribing is provided by the National Association of Statutory Health Insurance Physicians (KBV).
What you can bill
The prescription itself has been part of the basic, insured-person and consultation flat rates since 2023; there is no entitlement to separate reimbursement.
Accompanying services such as monitoring progress, by contrast, are remunerated outside the budget: for permanently listed DiGA via dedicated fee schedule items (GOP 01471 to 01479, 01481 to 01483, 30780 to 30782), and for provisionally listed DiGA via flat rate 86700 (Annex 34 to the Federal Collective Agreement for Physicians).
The DiGA directory shows which GOP belongs to which DiGA. Point values and billing rules can be found in the Online EBM, and the KBV provides an overview. The respective DiGA manufacturer can also help with any questions.
Frequently asked questions
Recourse risk and prevention
Wie hoch ist das Regressrisiko bei DiGA-Verordnungen?
A recourse claim requires a prescription to have been challenged as inefficient. Prescribing in line with the indication and documenting the decision is the best way to prevent such a challenge.
Like all areas of care, DiGA prescriptions are subject to the efficiency requirement under § 12 SGB V. At the same time, they are budget-neutral: neither the pharmaceutical nor the remedies budget is charged, and DiGA prescriptions fall outside the target volume.
In addition, individual audits are only carried out at the request of a statutory health insurer and only where the regional audit agreement covers DiGA at all. There are no systematic audits, such as quotas or target volumes, for DiGA.
Wie beuge ich einem Regress konkret vor?
Check and justify the medical indication in line with the information in the DiGA directory: diagnosis, contraindications and patient group, including exclusion criteria.
Record these points in the patient record, together with a medical justification of necessity. That way, you will have all the information to hand in the event of a later audit.
Helpful in individual cases: a reference to guidelines or the evidence base, and a note on therapy options that have been exhausted or are being used alongside.
Sind vorläufig gelistete DiGA riskanter als dauerhaft gelistete?
Listing status makes no difference to the entitlement to benefits. Both forms of listing establish this entitlement equally under § 33a(1) SGB V.
Every DiGA listed in the DiGA directory, regardless of its listing status, can be prescribed and reimbursed at the expense of the statutory health insurance (SHI).
Wer haftet für Fehlanwendungen und Nebenwirkungen?
Liability depends on fault, in the same way as when prescribing other medical devices.
As a rule, the manufacturer is primarily liable for damage caused by product defects. Manufacturers are obliged to ensure that their DiGA can be used without errors.
Your responsibility is to use the DiGA in line with its indication: the diagnosis must be present and all contraindications must be ruled out.
Documentation and audit procedures
Was sollte ich dokumentieren?
Ideally, document:
- that the indication is present, including the diagnosis as listed in the DiGA directory,
- that contraindications have been ruled out,
- that the patient group (exclusion criteria) has been taken into account,
- a medical justification of necessity.
For follow-up prescriptions, it is also helpful to record the course of therapy and why continuing it is appropriate.
Wer prüft die Wirtschaftlichkeit von DiGA-Verordnungen?
The regional joint audit bodies (Gemeinsame Prüfstellen) of the Associations of SHI Physicians and the statutory health insurers. Individual audits are only carried out at the request of a statutory health insurer and only where the regional audit agreement covers DiGA. This is not the case in every KV region.
Was tun bei einem Prüfverfahren?
- Check the audit request for formal criteria such as deadlines.
- Check whether the audit agreement that applies to you covers DiGA at all.
- If necessary, consult a specialist lawyer and request access to the files.
- The deadline for submitting a statement can be extended on request.
- Review your documentation and prepare a statement with supporting documents. Manufacturers will provide study data and evidence on request.
- A personal hearing is possible on request.
Billing and budget
Wird die Verordnung zusätzlich vergütet?
Since 2023, the prescription itself has been part of the basic, insured-person and consultation flat rates and can therefore no longer be billed separately.
Medical and psychotherapeutic activities related to the DiGA, such as monitoring progress, are, by contrast, remunerated outside the budget:
- permanently listed DiGA: via the GOP assigned to each in the EBM,
- provisionally listed DiGA: via flat rate 86700 (Annex 34 to the Federal Collective Agreement for Physicians).
Details such as point values and billing rules can be found in the Online EBM. The KBV provides an overview of all DiGA with their GOP or flat rate.
Zählen DiGA-Verordnungen in mein Praxisbudget?
No. There is currently no expenditure volume for DiGA; as material costs, they are not subject to budgeting. However, the prescription must be medically indicated.
The SHI physician services related to DiGA are also remunerated outside the budget. They are currently not counted towards the standard service volume (Regelleistungsvolumen), so you need not worry about budget limits or quotas.
Rechtlicher Hintergrund
Statutory health insurers pay for certain EBM services in addition to the morbidity-based total remuneration. These extra-budgetary services are either defined by law or agreed by the regional contracting parties. Under § 87a(3) sentence 6 SGB V, services can also be remunerated outside the budget if they are to be specifically promoted or if this is medically necessary. For several years, most recently with effect from 1 January 2025, the Valuation Committee (Bewertungsausschuss) has recommended not including DiGA-related services (GOP 01471 to 01479, 01481 to 01483, 30780 to 30782) in the morbidity-based total remuneration.
Gibt es eine Höchstzahl an DiGA pro Quartal?
Not at present. As there is currently no expenditure volume and therefore no budgeting for DiGA, there is no quota either. However, every prescription must be medically indicated.
Prescribing in practice
Kann ich mehrere DiGA auf ein Rezept setzen?
No. Only one DiGA may be prescribed per prescription, unlike medicines, for example.
Kann ich mehrere DiGA parallel verordnen?
Yes, provided it is medically indicated, different DiGA can be used in parallel for different indications. Document each indication and justify the parallel use.
Sind Folgeverordnungen für dieselbe DiGA möglich?
Yes, if the DiGA is still medically indicated. Record the medical justification for the follow-up prescription and the course of therapy so far.
Dürfen Ärztinnen und Ärzte in Kliniken DiGA verordnen?
Yes. Under the Framework Agreement on Discharge Management (§ 39(1a) SGB V), employed hospital physicians can prescribe DiGA as part of discharge management. As in outpatient care, the Muster 16 prescription form is used.
Ist eine Kostenübernahme auch ohne ärztliche Verordnung möglich?
Yes. If patients provide proof of the required indication to their statutory health insurer, the insurer will issue the activation code even without a prescription.
Statutory health insurers are legally obliged to review the proof of indication submitted and may refuse to issue the code in the case of contraindications or other exclusion criteria.
This right of review applies exclusively to the approval procedure, not to your medical prescription.
Quellen und Rechtsgrundlagen
- BfArM DiGA directory
- National Association of Statutory Health Insurance Physicians (KBV): prescribing DiGA
- Online EBM
- § 33a SGB V (entitlement to digital health applications)
- § 12 SGB V (efficiency requirement) and § 87a SGB V
- Federal Office for Social Security (BAS): circular on reviewing the necessity of prescribed DiGA under § 33a SGB V
- Federal Office for Social Security (BAS): circular on the review obligations and rights of statutory health insurers when issuing DiGA
- Framework Agreement on Discharge Management under § 39(1a) SGB V
This information reflects the situation at the date stated and does not replace legal advice in individual cases. The statutory provisions in force and the regional audit agreements of your Association of SHI Physicians are authoritative.
Do you have questions about prescribing DiGA efficiently? Write to us at kontakt@digitalversorgt.de.